• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-199a-3p 通过靶向癌基因 YAP1 抑制卵巢癌细胞活力。

MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.

机构信息

Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, P.R. China.

Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.

出版信息

Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11876. Epub 2021 Feb 4.

DOI:10.3892/mmr.2021.11876
PMID:33537822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893722/
Abstract

MicroRNA‑199a‑3p (miR‑199a‑3p) is aberrantly expressed in various types of cancer where it exhibits a tumor suppressive role. However, the biological role of miR‑199a‑3p in ovarian cancer (OC) remains unclear. The present study aimed to investigate whether miR‑199a‑3p was a tumor suppressor in OC and to identify the possible mechanisms. It was found that miR‑199a‑3p expression was significantly downregulated in the tumor tissues and blood samples of patients with OC, as well as in three OC cell lines. In addition, its low expression was closely associated with International Federation of Gynecology and Obstetrics disease stage, histological grade and lymph node metastasis. It was demonstrated that overexpression of miR‑199a‑3p inhibited the viability and promoted apoptosis of OV90 and SKOV‑3 cells. In addition, Yes‑associated protein 1 (YAP1), a well‑known oncogene, was identified as a direct target of miR‑199a‑3p in OC cells. Additionally, it was observed that YAP1 was significantly increased and inversely correlated with miR‑199a‑3p expression in OC tissues. Notably, YAP1 overexpression abrogated the tumor suppressive effects of miR‑199a‑3p . Collectively, the present results indicated that miR‑199a‑3p suppressed viability in OC cells, at least partly via inhibiting the YAP1 oncogene, suggesting that miR‑199a‑3p may act as a biomarker and therapeutic target for patients with OC.

摘要

微小 RNA-199a-3p(miR-199a-3p)在各种类型的癌症中表达异常,在这些癌症中发挥肿瘤抑制作用。然而,miR-199a-3p 在卵巢癌(OC)中的生物学作用尚不清楚。本研究旨在探讨 miR-199a-3p 是否在 OC 中起肿瘤抑制作用,并确定可能的机制。结果发现,miR-199a-3p 在 OC 患者的肿瘤组织和血液样本以及三种 OC 细胞系中表达明显下调。此外,其低表达与国际妇产科联合会疾病分期、组织学分级和淋巴结转移密切相关。研究表明,miR-199a-3p 的过表达抑制了 OV90 和 SKOV-3 细胞的活力并促进了细胞凋亡。此外,Yes 相关蛋白 1(YAP1),一种众所周知的癌基因,被鉴定为 OC 细胞中 miR-199a-3p 的直接靶标。此外,还观察到 YAP1 在 OC 组织中显著增加且与 miR-199a-3p 表达呈负相关。值得注意的是,YAP1 的过表达消除了 miR-199a-3p 的肿瘤抑制作用。综上所述,本研究结果表明,miR-199a-3p 通过抑制 YAP1 癌基因抑制 OC 细胞的活力,至少部分发挥作用,提示 miR-199a-3p 可能作为 OC 患者的生物标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/b4b8cf81a849/mmr-23-04-11876-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/2dae6b87e73d/mmr-23-04-11876-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/e21b7da313c6/mmr-23-04-11876-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/e7e6cea3a1b3/mmr-23-04-11876-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/b4b8cf81a849/mmr-23-04-11876-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/2dae6b87e73d/mmr-23-04-11876-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/e21b7da313c6/mmr-23-04-11876-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/e7e6cea3a1b3/mmr-23-04-11876-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a509/7893722/b4b8cf81a849/mmr-23-04-11876-g03.jpg

相似文献

1
MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.微小 RNA-199a-3p 通过靶向癌基因 YAP1 抑制卵巢癌细胞活力。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11876. Epub 2021 Feb 4.
2
MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.miRNA-15a-5p 靶向癌基因 YAP1 抑制宫颈癌细胞活力并诱导细胞凋亡。
Int J Mol Med. 2020 Oct;46(4):1301-1310. doi: 10.3892/ijmm.2020.4704. Epub 2020 Aug 12.
3
Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.miRNA-375 启动子甲基化促进卵巢癌细胞恶性进展的机制。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820980115. doi: 10.1177/1533033820980115.
4
MicroRNA‑199a‑3p suppresses high glucose‑induced apoptosis and inflammation by regulating the IKKβ/NF‑κB signaling pathway in renal tubular epithelial cells.微小 RNA-199a-3p 通过调节肾近端小管细胞中 IKKβ/NF-κB 信号通路抑制高糖诱导的细胞凋亡和炎症。
Int J Mol Med. 2020 Dec;46(6):2161-2171. doi: 10.3892/ijmm.2020.4751. Epub 2020 Oct 12.
5
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
6
MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.MicroRNA-545 通过直接结合和间接调控涉及 KDM4B 介导的去甲基化来调节 PLK1 表达,从而抑制卵巢癌的进展。
BMC Cancer. 2021 Feb 15;21(1):163. doi: 10.1186/s12885-021-07830-8.
7
miR‑199a‑3p/Sp1/LDHA axis controls aerobic glycolysis in testicular tumor cells.miR-199a-3p/Sp1/LDHA 轴控制睾丸肿瘤细胞的有氧糖酵解。
Int J Mol Med. 2018 Oct;42(4):2163-2174. doi: 10.3892/ijmm.2018.3771. Epub 2018 Jul 12.
8
Interaction of YAP1 and mTOR promotes bladder cancer progression.YAP1 和 mTOR 的相互作用促进膀胱癌的进展。
Int J Oncol. 2020 Jan;56(1):232-242. doi: 10.3892/ijo.2019.4922. Epub 2019 Nov 25.
9
Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma.Yes相关蛋白1在卵巢浆液性囊腺癌中的表达及其临床意义
Oncol Rep. 2017 May;37(5):2620-2632. doi: 10.3892/or.2017.5517. Epub 2017 Mar 21.
10
miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.miR-96-5p 通过抑制 Cav-1 促进卵巢癌细胞的增殖和迁移。
J Ovarian Res. 2019 Jun 22;12(1):57. doi: 10.1186/s13048-019-0533-1.

引用本文的文献

1
Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved.了解妊娠如何预防卵巢和子宫内膜癌的发生:可能涉及胎儿抗原。
Endocrinology. 2022 Oct 11;163(11). doi: 10.1210/endocr/bqac141.
2
miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer.miR-199a:肺癌中具有非编码 RNA 网络的肿瘤抑制因子和治疗候选物。
Int J Mol Sci. 2022 Jul 31;23(15):8518. doi: 10.3390/ijms23158518.
3
The Role of microRNA in Pancreatic Cancer.微小RNA在胰腺癌中的作用

本文引用的文献

1
[YAP1 knockdown suppresses the proliferation, migration and invasion of human nasopharyngeal carcinoma cells].[YAP1基因敲低抑制人鼻咽癌细胞的增殖、迁移和侵袭]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Mar 30;39(3):286-291. doi: 10.12122/j.issn.1673-4254.2019.03.05.
2
MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.微小 RNA-345 通过直接靶向 YAP1 抑制非小细胞肺癌细胞的侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2436-2443. doi: 10.26355/eurrev_201903_17390.
3
miR‑145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3.
Biomedicines. 2021 Sep 26;9(10):1322. doi: 10.3390/biomedicines9101322.
miR-145 通过靶向 CCND2 和 E2F3 抑制细胞生长和侵袭来抑制卵巢癌的进展。
Mol Med Rep. 2019 May;19(5):3575-3583. doi: 10.3892/mmr.2019.10004. Epub 2019 Mar 5.
4
MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.微小RNA-199a-3p通过靶向p21激活激酶4降低食管癌细胞增殖。
Oncotarget. 2018 Jun 19;9(47):28391-28407. doi: 10.18632/oncotarget.25375.
5
MiR-199a-5p Inhibits the Growth and Metastasis of Colorectal Cancer Cells by Targeting ROCK1.微小RNA-199a-5p通过靶向ROCK1抑制结肠癌细胞的生长和转移。
Technol Cancer Res Treat. 2018 Jan 1;17:1533034618775509. doi: 10.1177/1533034618775509.
6
MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma.微小RNA-199a-3p在透明细胞肾细胞癌中发挥肿瘤抑制作用。
Pathol Res Pract. 2018 Jun;214(6):806-813. doi: 10.1016/j.prp.2018.05.005. Epub 2018 May 9.
7
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.miR-199a-3p 通过靶向 ITGB8 增强卵巢癌细胞对顺铂的敏感性。
Oncol Rep. 2018 Apr;39(4):1649-1657. doi: 10.3892/or.2018.6259. Epub 2018 Feb 12.
8
MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.微小 RNA-455 通过直接靶向 Notch1 抑制上皮性卵巢癌的细胞增殖和侵袭。
Mol Med Rep. 2017 Dec;16(6):9777-9785. doi: 10.3892/mmr.2017.7790. Epub 2017 Oct 13.
9
Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.通过启动子甲基化抑制 miR-199a-3p 促进 DDR1 表达,从而导致卵巢癌细胞侵袭性增加和对顺铂耐药。
J Ovarian Res. 2017 Jul 25;10(1):50. doi: 10.1186/s13048-017-0333-4.
10
MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal.微小RNA-199a-3p通过靶向ZHX1/PUMA信号抑制肝癌细胞的肿瘤发生。
Am J Transl Res. 2017 May 15;9(5):2457-2465. eCollection 2017.